

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.62829375 |
| 2 | DNA deamination (GO:0045006) | 6.21827209 |
| 3 | viral transcription (GO:0019083) | 6.18754431 |
| 4 | translational termination (GO:0006415) | 5.95251342 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 5.32466921 |
| 6 | translational elongation (GO:0006414) | 5.31071473 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 5.24332023 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.05401648 |
| 9 | protein targeting to ER (GO:0045047) | 4.90027009 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.89606880 |
| 11 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.89326876 |
| 12 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.86611422 |
| 13 | translational initiation (GO:0006413) | 4.77120778 |
| 14 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.71755088 |
| 15 | viral life cycle (GO:0019058) | 4.70710989 |
| 16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.64635125 |
| 17 | DNA strand elongation (GO:0022616) | 4.62901267 |
| 18 | protein localization to endoplasmic reticulum (GO:0070972) | 4.62737728 |
| 19 | cellular protein complex disassembly (GO:0043624) | 4.59449531 |
| 20 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.26583593 |
| 21 | DNA unwinding involved in DNA replication (GO:0006268) | 4.20966203 |
| 22 | DNA replication initiation (GO:0006270) | 4.18618521 |
| 23 | protein complex disassembly (GO:0043241) | 4.17098485 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 4.14026990 |
| 25 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.12539682 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 4.01578359 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 4.01578359 |
| 28 | telomere maintenance via recombination (GO:0000722) | 3.99428601 |
| 29 | formation of translation preinitiation complex (GO:0001731) | 3.95873331 |
| 30 | macromolecular complex disassembly (GO:0032984) | 3.92028828 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.85205405 |
| 32 | nucleobase biosynthetic process (GO:0046112) | 3.84973112 |
| 33 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.84641079 |
| 34 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.81205797 |
| 35 | establishment of viral latency (GO:0019043) | 3.76369764 |
| 36 | ribosome biogenesis (GO:0042254) | 3.76236770 |
| 37 | rRNA modification (GO:0000154) | 3.74930980 |
| 38 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.74444397 |
| 39 | pseudouridine synthesis (GO:0001522) | 3.74407099 |
| 40 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.74401766 |
| 41 | mitotic recombination (GO:0006312) | 3.62127862 |
| 42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.59008037 |
| 43 | purine nucleobase biosynthetic process (GO:0009113) | 3.58479672 |
| 44 | mRNA catabolic process (GO:0006402) | 3.57176897 |
| 45 | nuclear envelope reassembly (GO:0031468) | 3.56370103 |
| 46 | mitotic nuclear envelope reassembly (GO:0007084) | 3.56370103 |
| 47 | telomere maintenance via telomere lengthening (GO:0010833) | 3.55049949 |
| 48 | protein maturation by protein folding (GO:0022417) | 3.54050567 |
| 49 | regulation of chronic inflammatory response (GO:0002676) | 3.53913361 |
| 50 | rRNA processing (GO:0006364) | 3.53533617 |
| 51 | translation (GO:0006412) | 3.52560202 |
| 52 | RNA catabolic process (GO:0006401) | 3.45965088 |
| 53 | rRNA metabolic process (GO:0016072) | 3.38895662 |
| 54 | proteasome assembly (GO:0043248) | 3.34604743 |
| 55 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.34343901 |
| 56 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.29627221 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28990330 |
| 58 | negative regulation of RNA splicing (GO:0033119) | 3.27956328 |
| 59 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.27623383 |
| 60 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.25991406 |
| 61 | protein targeting to membrane (GO:0006612) | 3.24262996 |
| 62 | folic acid metabolic process (GO:0046655) | 3.23835661 |
| 63 | IMP biosynthetic process (GO:0006188) | 3.23231542 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22248314 |
| 65 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.20491571 |
| 66 | peptidyl-arginine methylation (GO:0018216) | 3.20287097 |
| 67 | peptidyl-arginine N-methylation (GO:0035246) | 3.20287097 |
| 68 | iron-sulfur cluster assembly (GO:0016226) | 3.19899443 |
| 69 | metallo-sulfur cluster assembly (GO:0031163) | 3.19899443 |
| 70 | rRNA methylation (GO:0031167) | 3.19819617 |
| 71 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.19405310 |
| 72 | spliceosomal snRNP assembly (GO:0000387) | 3.18952432 |
| 73 | cellular component biogenesis (GO:0044085) | 3.16971666 |
| 74 | amino sugar catabolic process (GO:0046348) | 3.15083638 |
| 75 | protein localization to kinetochore (GO:0034501) | 3.13878038 |
| 76 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.13675360 |
| 77 | lipopolysaccharide metabolic process (GO:0008653) | 3.11426530 |
| 78 | regulation of podosome assembly (GO:0071801) | 3.11176767 |
| 79 | histone arginine methylation (GO:0034969) | 3.10249941 |
| 80 | DNA replication checkpoint (GO:0000076) | 3.09221593 |
| 81 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.06503574 |
| 82 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.06503574 |
| 83 | GDP-mannose metabolic process (GO:0019673) | 3.04774070 |
| 84 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.03752302 |
| 85 | tRNA methylation (GO:0030488) | 2.99663023 |
| 86 | type I interferon signaling pathway (GO:0060337) | 2.98702104 |
| 87 | cellular response to type I interferon (GO:0071357) | 2.98702104 |
| 88 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.98029089 |
| 89 | regulation of chemokine biosynthetic process (GO:0045073) | 2.96532593 |
| 90 | mitotic nuclear envelope disassembly (GO:0007077) | 2.95906792 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 2.95068894 |
| 92 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.95068894 |
| 93 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.94986317 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92263233 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.92263233 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 2.90410711 |
| 97 | response to peptidoglycan (GO:0032494) | 2.89099443 |
| 98 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.87067934 |
| 99 | response to type I interferon (GO:0034340) | 2.86321238 |
| 100 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85323590 |
| 101 | translesion synthesis (GO:0019985) | 2.84157156 |
| 102 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.83574615 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.83398330 |
| 104 | ribosome assembly (GO:0042255) | 2.82370002 |
| 105 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.81825031 |
| 106 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81589077 |
| 107 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.81388309 |
| 108 | pentose-phosphate shunt (GO:0006098) | 2.81203353 |
| 109 | de novo posttranslational protein folding (GO:0051084) | 2.80017849 |
| 110 | chaperone-mediated protein transport (GO:0072321) | 2.78569238 |
| 111 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.78122159 |
| 112 | IMP metabolic process (GO:0046040) | 2.77806707 |
| 113 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77091390 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.77052693 |
| 115 | spliceosomal complex assembly (GO:0000245) | 2.76064114 |
| 116 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.74574955 |
| 117 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.74444179 |
| 118 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.74444179 |
| 119 | ncRNA 3-end processing (GO:0043628) | 2.74136965 |
| 120 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.74067129 |
| 121 | protein localization to chromosome, centromeric region (GO:0071459) | 2.73098758 |
| 122 | mRNA splicing, via spliceosome (GO:0000398) | 2.73053820 |
| 123 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.73053820 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72926552 |
| 125 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.72404803 |
| 126 | negative regulation of mRNA processing (GO:0050686) | 2.72345466 |
| 127 | positive regulation of interleukin-17 production (GO:0032740) | 2.71956835 |
| 128 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.71092240 |
| 129 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.70577018 |
| 130 | nuclear envelope disassembly (GO:0051081) | 2.70366050 |
| 131 | membrane disassembly (GO:0030397) | 2.70366050 |
| 132 | telomere organization (GO:0032200) | 2.69903538 |
| 133 | cellular response to interferon-beta (GO:0035458) | 2.69734658 |
| 134 | RNA splicing, via transesterification reactions (GO:0000375) | 2.69686905 |
| 135 | regulation of mitochondrial translation (GO:0070129) | 2.69457788 |
| 136 | negative regulation of ligase activity (GO:0051352) | 2.69125431 |
| 137 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.69125431 |
| 138 | telomere maintenance (GO:0000723) | 2.69021532 |
| 139 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.69008927 |
| 140 | de novo protein folding (GO:0006458) | 2.66783594 |
| 141 | CENP-A containing nucleosome assembly (GO:0034080) | 2.65151553 |
| 142 | DNA replication-independent nucleosome organization (GO:0034724) | 2.64615822 |
| 143 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.64615822 |
| 144 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.63952539 |
| 145 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.63952539 |
| 146 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.61653356 |
| 147 | positive regulation of mitochondrial fission (GO:0090141) | 2.61467807 |
| 148 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.61457350 |
| 149 | positive regulation of interleukin-10 production (GO:0032733) | 2.61232049 |
| 150 | peptidyl-histidine modification (GO:0018202) | 2.60196153 |
| 151 | establishment of integrated proviral latency (GO:0075713) | 2.60034994 |
| 152 | ncRNA processing (GO:0034470) | 2.59892078 |
| 153 | chromatin remodeling at centromere (GO:0031055) | 2.59832570 |
| 154 | RNA methylation (GO:0001510) | 2.59214295 |
| 155 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58601182 |
| 156 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.58280893 |
| 157 | protein deneddylation (GO:0000338) | 2.57074510 |
| 158 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.56663546 |
| 159 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.56663546 |
| 160 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.56663546 |
| 161 | immunoglobulin mediated immune response (GO:0016064) | 2.55773661 |
| 162 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.55442458 |
| 163 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.55429152 |
| 164 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.55104825 |
| 165 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.52799899 |
| 166 | protein targeting to mitochondrion (GO:0006626) | 2.52217086 |
| 167 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.50412216 |
| 168 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.49492819 |
| 169 | DNA damage response, detection of DNA damage (GO:0042769) | 2.49416522 |
| 170 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48846528 |
| 171 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48846528 |
| 172 | regulation of translation in response to stress (GO:0043555) | 2.47865147 |
| 173 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.46555889 |
| 174 | cullin deneddylation (GO:0010388) | 2.46507954 |
| 175 | response to interferon-beta (GO:0035456) | 2.46147844 |
| 176 | axonemal dynein complex assembly (GO:0070286) | 2.45495529 |
| 177 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.43591182 |
| 178 | cellular response to virus (GO:0098586) | 2.42373530 |
| 179 | base-excision repair, AP site formation (GO:0006285) | 2.42196930 |
| 180 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.38507543 |
| 181 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.36704006 |
| 182 | GTP biosynthetic process (GO:0006183) | 2.36432566 |
| 183 | positive regulation of ligase activity (GO:0051351) | 2.36084864 |
| 184 | purine nucleotide salvage (GO:0032261) | 2.35482802 |
| 185 | negative regulation of protein ubiquitination (GO:0031397) | 2.35153395 |
| 186 | activation of MAPKKK activity (GO:0000185) | 2.34813037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.32710045 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.07474131 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.06667362 |
| 4 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.78684477 |
| 5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.74554940 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.59422288 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.56237735 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.55757407 |
| 9 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.49930997 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.48441060 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.39952177 |
| 12 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.39918357 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.39546872 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.35352509 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.33767322 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.32967997 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.24728259 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24657098 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.23207991 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10510138 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.07569030 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.03961333 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03223842 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.99250094 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96654959 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95225270 |
| 27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94242489 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93567885 |
| 29 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79313460 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.75064927 |
| 31 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72892342 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67653883 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66234920 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65494029 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64318640 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63639924 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.61879082 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61469346 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59823368 |
| 40 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56835494 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55946211 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53495451 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51978905 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51577405 |
| 45 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.49598681 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48468707 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47787171 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47746070 |
| 49 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.46571572 |
| 50 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43720374 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42690209 |
| 52 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.42034057 |
| 53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.40580481 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40002158 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39755797 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39399357 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.38399555 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38391954 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34057949 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33857166 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33063913 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33060525 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31989766 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31628188 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31262073 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31000027 |
| 67 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30729356 |
| 68 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29091530 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.28849132 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27738650 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27557565 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26784743 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26124220 |
| 74 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24870458 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24418624 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23361644 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19450436 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19283207 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18900570 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18887371 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18608936 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18393339 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17825522 |
| 84 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16726721 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16417712 |
| 86 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.16230747 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15875957 |
| 88 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15519964 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15363554 |
| 90 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12394468 |
| 91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12031169 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11637559 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10046254 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.07518020 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07310503 |
| 96 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.07076735 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05035158 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04668331 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04232498 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03584223 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03522403 |
| 102 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03371980 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03359521 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02969836 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.02898104 |
| 106 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02773956 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01767492 |
| 108 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00710755 |
| 109 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00353767 |
| 110 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98617543 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97883848 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97322101 |
| 113 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96817871 |
| 114 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96801043 |
| 115 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96640383 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96342641 |
| 117 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94921882 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94858142 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94704540 |
| 120 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94379602 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94099397 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91232477 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90743949 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90106413 |
| 125 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90028778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.82584642 |
| 2 | MP0003303_peritoneal_inflammation | 4.16543966 |
| 3 | MP0008260_abnormal_autophagy | 3.82487848 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.79722433 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.59229800 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.53512034 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.51416324 |
| 8 | MP0002396_abnormal_hematopoietic_system | 3.50943139 |
| 9 | MP0003077_abnormal_cell_cycle | 3.27893575 |
| 10 | MP0006082_CNS_inflammation | 2.86864670 |
| 11 | MP0008057_abnormal_DNA_replication | 2.77072901 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.58206839 |
| 13 | MP0004510_myositis | 2.54069701 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.51685392 |
| 15 | MP0005451_abnormal_body_composition | 2.42587836 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.39607573 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.28805660 |
| 18 | MP0008058_abnormal_DNA_repair | 2.28603615 |
| 19 | MP0000343_altered_response_to | 2.26905048 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.25199719 |
| 21 | MP0003724_increased_susceptibility_to | 2.24218584 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 2.24022894 |
| 23 | MP0001545_abnormal_hematopoietic_system | 2.24022894 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.13159725 |
| 25 | MP0000490_abnormal_crypts_of | 2.10868218 |
| 26 | MP0005387_immune_system_phenotype | 2.02172373 |
| 27 | MP0001790_abnormal_immune_system | 2.02172373 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.99046320 |
| 29 | MP0001730_embryonic_growth_arrest | 1.92333995 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.92153566 |
| 31 | MP0002419_abnormal_innate_immunity | 1.89890555 |
| 32 | MP0009840_abnormal_foam_cell | 1.86566914 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.85606800 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.84215835 |
| 35 | MP0002398_abnormal_bone_marrow | 1.82385693 |
| 36 | MP0009764_decreased_sensitivity_to | 1.81189705 |
| 37 | MP0000350_abnormal_cell_proliferation | 1.79359649 |
| 38 | MP0003075_altered_response_to | 1.78703971 |
| 39 | MP0000685_abnormal_immune_system | 1.69458008 |
| 40 | MP0008932_abnormal_embryonic_tissue | 1.69293035 |
| 41 | MP0002722_abnormal_immune_system | 1.69286194 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.69074786 |
| 43 | MP0002019_abnormal_tumor_incidence | 1.69070772 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.67304418 |
| 45 | MP0002254_reproductive_system_inflammat | 1.63745976 |
| 46 | MP0000313_abnormal_cell_death | 1.56702418 |
| 47 | MP0001542_abnormal_bone_strength | 1.55741889 |
| 48 | MP0002429_abnormal_blood_cell | 1.52638073 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.51942807 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.50347031 |
| 51 | MP0002080_prenatal_lethality | 1.47419896 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.44261333 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.42009981 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.41989668 |
| 55 | MP0000716_abnormal_immune_system | 1.38906658 |
| 56 | MP0002132_abnormal_respiratory_system | 1.38703625 |
| 57 | MP0001697_abnormal_embryo_size | 1.37569453 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.35786645 |
| 59 | MP0001800_abnormal_humoral_immune | 1.35379637 |
| 60 | MP0005671_abnormal_response_to | 1.32426629 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.32022179 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.28604472 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.23374031 |
| 64 | MP0001819_abnormal_immune_cell | 1.22366358 |
| 65 | MP0000358_abnormal_cell_content/ | 1.22093515 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.21128267 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.21036278 |
| 68 | MP0003786_premature_aging | 1.20434437 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.20136970 |
| 70 | MP0001672_abnormal_embryogenesis/_devel | 1.16686036 |
| 71 | MP0005380_embryogenesis_phenotype | 1.16686036 |
| 72 | MP0003123_paternal_imprinting | 1.15921260 |
| 73 | MP0002723_abnormal_immune_serum | 1.15842220 |
| 74 | MP0000604_amyloidosis | 1.13616269 |
| 75 | MP0001853_heart_inflammation | 1.12999192 |
| 76 | MP0005257_abnormal_intraocular_pressure | 1.12384524 |
| 77 | MP0003646_muscle_fatigue | 1.11841058 |
| 78 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10827689 |
| 79 | MP0001243_abnormal_dermal_layer | 1.10498100 |
| 80 | MP0000751_myopathy | 1.10485198 |
| 81 | MP0005025_abnormal_response_to | 1.09833250 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.08946701 |
| 83 | MP0000858_altered_metastatic_potential | 1.08869204 |
| 84 | MP0002405_respiratory_system_inflammati | 1.06670206 |
| 85 | MP0004233_abnormal_muscle_weight | 1.06401515 |
| 86 | MP0003436_decreased_susceptibility_to | 1.05764858 |
| 87 | MP0001873_stomach_inflammation | 1.05130276 |
| 88 | MP0009278_abnormal_bone_marrow | 1.03326171 |
| 89 | MP0005501_abnormal_skin_physiology | 1.02930770 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 1.02920519 |
| 91 | MP0003984_embryonic_growth_retardation | 1.02468194 |
| 92 | MP0003186_abnormal_redox_activity | 1.02307481 |
| 93 | MP0002102_abnormal_ear_morphology | 1.01776990 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 1.01299854 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.00931493 |
| 96 | MP0002085_abnormal_embryonic_tissue | 0.98997371 |
| 97 | MP0005023_abnormal_wound_healing | 0.98498834 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.98186667 |
| 99 | MP0009785_altered_susceptibility_to | 0.98182105 |
| 100 | MP0003866_abnormal_defecation | 0.96573410 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.95929232 |
| 102 | MP0006054_spinal_hemorrhage | 0.93196981 |
| 103 | MP0005165_increased_susceptibility_to | 0.92920006 |
| 104 | MP0000749_muscle_degeneration | 0.92899473 |
| 105 | MP0005310_abnormal_salivary_gland | 0.91566931 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.91522940 |
| 107 | MP0002084_abnormal_developmental_patter | 0.89957807 |
| 108 | MP0004197_abnormal_fetal_growth/weight/ | 0.89734421 |
| 109 | MP0002006_tumorigenesis | 0.89187640 |
| 110 | MP0008004_abnormal_stomach_pH | 0.89176564 |
| 111 | MP0005166_decreased_susceptibility_to | 0.88101811 |
| 112 | MP0001293_anophthalmia | 0.87514543 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.87092457 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.87021580 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.85862772 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.85401592 |
| 117 | MP0000598_abnormal_liver_morphology | 0.85258705 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.85234284 |
| 119 | MP0010307_abnormal_tumor_latency | 0.85139984 |
| 120 | MP0005384_cellular_phenotype | 0.82573745 |
| 121 | MP0000747_muscle_weakness | 0.82235090 |
| 122 | MP0009763_increased_sensitivity_to | 0.80669830 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.80329666 |
| 124 | MP0002095_abnormal_skin_pigmentation | 0.80292854 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.80080689 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.80060099 |
| 127 | MP0008874_decreased_physiological_sensi | 0.79965677 |
| 128 | MP0003329_amyloid_beta_deposits | 0.79096858 |
| 129 | MP0001764_abnormal_homeostasis | 0.77930489 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.77759385 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.76449789 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.75330958 |
| 133 | MP0003191_abnormal_cellular_cholesterol | 0.74883144 |
| 134 | MP0003718_maternal_effect | 0.72430778 |
| 135 | MP0001915_intracranial_hemorrhage | 0.72317781 |
| 136 | MP0006292_abnormal_olfactory_placode | 0.71669267 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.68561084 |
| 138 | MP0002653_abnormal_ependyma_morphology | 0.68264777 |
| 139 | MP0001849_ear_inflammation | 0.68215419 |
| 140 | MP0003119_abnormal_digestive_system | 0.67144468 |
| 141 | MP0005266_abnormal_metabolism | 0.66654617 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.66537529 |
| 143 | MP0008770_decreased_survivor_rate | 0.66266115 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.65747853 |
| 145 | MP0008469_abnormal_protein_level | 0.65286268 |
| 146 | MP0004947_skin_inflammation | 0.65032056 |
| 147 | MP0009931_abnormal_skin_appearance | 0.64773867 |
| 148 | MP0000609_abnormal_liver_physiology | 0.64689016 |
| 149 | MP0002970_abnormal_white_adipose | 0.63622431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.12178763 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.77322415 |
| 3 | Reticulocytopenia (HP:0001896) | 5.18460886 |
| 4 | Aplastic anemia (HP:0001915) | 4.79144037 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.57927935 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.57927935 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.57927935 |
| 8 | Oral leukoplakia (HP:0002745) | 4.16275244 |
| 9 | Macrocytic anemia (HP:0001972) | 4.03085837 |
| 10 | Colon cancer (HP:0003003) | 3.91262722 |
| 11 | IgM deficiency (HP:0002850) | 3.87221503 |
| 12 | Pallor (HP:0000980) | 3.86599505 |
| 13 | Thrombocytosis (HP:0001894) | 3.71877474 |
| 14 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.52542485 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.50650189 |
| 16 | Selective tooth agenesis (HP:0001592) | 3.37582434 |
| 17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.35716022 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 3.35128463 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 3.15502362 |
| 20 | Cholecystitis (HP:0001082) | 3.15502362 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.13650334 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.03761148 |
| 23 | Loss of speech (HP:0002371) | 3.01589079 |
| 24 | Birth length less than 3rd percentile (HP:0003561) | 2.98797737 |
| 25 | Increased IgM level (HP:0003496) | 2.91033712 |
| 26 | Microretrognathia (HP:0000308) | 2.90599142 |
| 27 | Abnormality of glycolysis (HP:0004366) | 2.88021667 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.87804387 |
| 29 | Increased serum pyruvate (HP:0003542) | 2.87490985 |
| 30 | Chronic otitis media (HP:0000389) | 2.86567946 |
| 31 | Shoulder girdle muscle weakness (HP:0003547) | 2.83225697 |
| 32 | Prolonged neonatal jaundice (HP:0006579) | 2.82981708 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79843260 |
| 34 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79843260 |
| 35 | Mutism (HP:0002300) | 2.78622073 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.77469355 |
| 37 | Ependymoma (HP:0002888) | 2.76007452 |
| 38 | Hand muscle atrophy (HP:0009130) | 2.74023444 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.73449174 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.72651066 |
| 41 | Petechiae (HP:0000967) | 2.71402314 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.71186791 |
| 43 | Carpal bone hypoplasia (HP:0001498) | 2.70448777 |
| 44 | Breast hypoplasia (HP:0003187) | 2.64339448 |
| 45 | Multiple enchondromatosis (HP:0005701) | 2.62274695 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.57327588 |
| 47 | Hyperacusis (HP:0010780) | 2.56868067 |
| 48 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.56798985 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.55582370 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.55558000 |
| 51 | Upper limb muscle weakness (HP:0003484) | 2.52342846 |
| 52 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.51605723 |
| 53 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.51605723 |
| 54 | Nuclear cataract (HP:0100018) | 2.51186368 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.50102842 |
| 56 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.44440574 |
| 57 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.44440574 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.42307051 |
| 59 | Acute encephalopathy (HP:0006846) | 2.40891565 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.40419427 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.40419427 |
| 62 | Ragged-red muscle fibers (HP:0003200) | 2.38023657 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.37462143 |
| 64 | Orchitis (HP:0100796) | 2.37271867 |
| 65 | Pancytopenia (HP:0001876) | 2.34834248 |
| 66 | Secondary amenorrhea (HP:0000869) | 2.34714310 |
| 67 | Pelvic girdle muscle weakness (HP:0003749) | 2.33952415 |
| 68 | Hypertensive crisis (HP:0100735) | 2.31513277 |
| 69 | Exercise intolerance (HP:0003546) | 2.31048377 |
| 70 | Increased CSF lactate (HP:0002490) | 2.30430501 |
| 71 | Abnormality of reticulocytes (HP:0004312) | 2.30079608 |
| 72 | Diminished motivation (HP:0000745) | 2.30015473 |
| 73 | Agnosia (HP:0010524) | 2.29059892 |
| 74 | Myositis (HP:0100614) | 2.28742712 |
| 75 | Disinhibition (HP:0000734) | 2.28693685 |
| 76 | Neoplasm of the pancreas (HP:0002894) | 2.28611600 |
| 77 | Premature graying of hair (HP:0002216) | 2.28597347 |
| 78 | Degeneration of anterior horn cells (HP:0002398) | 2.27928590 |
| 79 | Abnormality of the anterior horn cell (HP:0006802) | 2.27928590 |
| 80 | Muscle fiber atrophy (HP:0100295) | 2.27725541 |
| 81 | Axonal loss (HP:0003447) | 2.26841684 |
| 82 | Recurrent abscess formation (HP:0002722) | 2.26597379 |
| 83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.25141473 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.24178858 |
| 85 | 11 pairs of ribs (HP:0000878) | 2.21418300 |
| 86 | Trismus (HP:0000211) | 2.20245530 |
| 87 | Abnormal number of incisors (HP:0011064) | 2.20025901 |
| 88 | Limb-girdle muscle atrophy (HP:0003797) | 2.19972719 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.19614336 |
| 90 | Optic neuritis (HP:0100653) | 2.19614336 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.18260323 |
| 92 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16719055 |
| 93 | Abnormal ciliary motility (HP:0012262) | 2.15081029 |
| 94 | Absent thumb (HP:0009777) | 2.15039812 |
| 95 | Parakeratosis (HP:0001036) | 2.14671779 |
| 96 | Apathy (HP:0000741) | 2.14328483 |
| 97 | Rhinitis (HP:0012384) | 2.10705160 |
| 98 | Basal cell carcinoma (HP:0002671) | 2.08333054 |
| 99 | Acute lymphatic leukemia (HP:0006721) | 2.08028602 |
| 100 | Lymphoma (HP:0002665) | 2.07752134 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.07385922 |
| 102 | Prolonged bleeding time (HP:0003010) | 2.07139515 |
| 103 | Premature ovarian failure (HP:0008209) | 2.07098714 |
| 104 | Entropion (HP:0000621) | 2.06933700 |
| 105 | Lactic acidosis (HP:0003128) | 2.05416342 |
| 106 | Respiratory failure (HP:0002878) | 2.03686212 |
| 107 | Megaloblastic anemia (HP:0001889) | 2.02570059 |
| 108 | Stomatitis (HP:0010280) | 1.99838669 |
| 109 | IgG deficiency (HP:0004315) | 1.96264143 |
| 110 | Patellar aplasia (HP:0006443) | 1.95836254 |
| 111 | Type I transferrin isoform profile (HP:0003642) | 1.95533529 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.93818784 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 1.93208602 |
| 114 | Myelodysplasia (HP:0002863) | 1.91809832 |
| 115 | Rhabdomyolysis (HP:0003201) | 1.91368150 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.90694379 |
| 117 | Hepatocellular necrosis (HP:0001404) | 1.89684457 |
| 118 | Progressive macrocephaly (HP:0004481) | 1.89612129 |
| 119 | Fasciculations (HP:0002380) | 1.89512622 |
| 120 | Personality changes (HP:0000751) | 1.89183336 |
| 121 | Systemic lupus erythematosus (HP:0002725) | 1.88552785 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.88385144 |
| 123 | Amaurosis fugax (HP:0100576) | 1.87817092 |
| 124 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.87271070 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.86689205 |
| 126 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86503188 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 1.86292416 |
| 128 | Abnormality of T cells (HP:0002843) | 1.85569976 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 1.85392311 |
| 130 | Sparse eyelashes (HP:0000653) | 1.85344635 |
| 131 | Cellular immunodeficiency (HP:0005374) | 1.85307744 |
| 132 | Broad distal phalanx of finger (HP:0009836) | 1.85040814 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.84839040 |
| 134 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84454809 |
| 135 | Increased serum ferritin (HP:0003281) | 1.84431592 |
| 136 | Vertebral compression fractures (HP:0002953) | 1.83536397 |
| 137 | Hypokinesia (HP:0002375) | 1.83405268 |
| 138 | Hepatic necrosis (HP:0002605) | 1.82775685 |
| 139 | Medulloblastoma (HP:0002885) | 1.82110736 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.82054707 |
| 141 | Poor head control (HP:0002421) | 1.81904142 |
| 142 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.79980098 |
| 143 | Type 2 muscle fiber atrophy (HP:0003554) | 1.79590402 |
| 144 | Increased serum lactate (HP:0002151) | 1.78428434 |
| 145 | Bone marrow hypocellularity (HP:0005528) | 1.74865557 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.74830721 |
| 147 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73602379 |
| 148 | Broad face (HP:0000283) | 1.72898998 |
| 149 | Slender long bone (HP:0003100) | 1.72067040 |
| 150 | Abnormal neuron morphology (HP:0012757) | 1.69675575 |
| 151 | Abnormality of the motor neurons (HP:0002450) | 1.69675575 |
| 152 | Squamous cell carcinoma (HP:0002860) | 1.69215093 |
| 153 | Poikiloderma (HP:0001029) | 1.69015014 |
| 154 | Impaired platelet aggregation (HP:0003540) | 1.68401353 |
| 155 | Abnormal platelet function (HP:0011869) | 1.68401353 |
| 156 | Increased muscle lipid content (HP:0009058) | 1.66508480 |
| 157 | Pulmonary fibrosis (HP:0002206) | 1.65967126 |
| 158 | Emotional lability (HP:0000712) | 1.64885182 |
| 159 | Nasal polyposis (HP:0100582) | 1.64431753 |
| 160 | Epistaxis (HP:0000421) | 1.64242177 |
| 161 | Prominent nose (HP:0000448) | 1.63466001 |
| 162 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.61703660 |
| 163 | Death in infancy (HP:0001522) | 1.61306357 |
| 164 | Spastic diplegia (HP:0001264) | 1.60660492 |
| 165 | Exertional dyspnea (HP:0002875) | 1.60087766 |
| 166 | Angiofibromas (HP:0010615) | 1.59343763 |
| 167 | Adenoma sebaceum (HP:0009720) | 1.59343763 |
| 168 | Pustule (HP:0200039) | 1.59299554 |
| 169 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59085594 |
| 170 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59085594 |
| 171 | Abnormal protein glycosylation (HP:0012346) | 1.59085594 |
| 172 | Abnormal glycosylation (HP:0012345) | 1.59085594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.55390396 |
| 2 | BUB1 | 3.70006482 |
| 3 | WEE1 | 3.62928581 |
| 4 | IRAK3 | 3.08340759 |
| 5 | TESK1 | 3.04544583 |
| 6 | EEF2K | 2.59451151 |
| 7 | VRK2 | 2.54863129 |
| 8 | STK16 | 2.53365880 |
| 9 | MAP4K1 | 2.43908066 |
| 10 | RPS6KA4 | 2.29575764 |
| 11 | BRD4 | 2.24323164 |
| 12 | ARAF | 2.20245772 |
| 13 | RPS6KB2 | 2.10144447 |
| 14 | CDC7 | 2.05823135 |
| 15 | NEK2 | 2.01769554 |
| 16 | FLT3 | 1.96060705 |
| 17 | PKN2 | 1.94842957 |
| 18 | TESK2 | 1.93914937 |
| 19 | PIM2 | 1.93167855 |
| 20 | KDR | 1.93073905 |
| 21 | TGFBR1 | 1.89239212 |
| 22 | EIF2AK1 | 1.87054330 |
| 23 | DYRK3 | 1.85449854 |
| 24 | ACVR1B | 1.82526938 |
| 25 | MAP2K7 | 1.79455054 |
| 26 | KIT | 1.77829053 |
| 27 | MAP3K10 | 1.67617178 |
| 28 | GRK7 | 1.66787338 |
| 29 | LIMK1 | 1.62744276 |
| 30 | BCKDK | 1.61942293 |
| 31 | PASK | 1.60382324 |
| 32 | TLK1 | 1.56884405 |
| 33 | SRPK1 | 1.55611583 |
| 34 | TRIB3 | 1.54378434 |
| 35 | MAP3K11 | 1.48752761 |
| 36 | JAK3 | 1.46933436 |
| 37 | LRRK2 | 1.46143506 |
| 38 | PRPF4B | 1.43777783 |
| 39 | SCYL2 | 1.40161464 |
| 40 | BTK | 1.39466982 |
| 41 | MAPKAPK3 | 1.38912982 |
| 42 | PAK6 | 1.37960421 |
| 43 | BRSK2 | 1.37366466 |
| 44 | PAK4 | 1.31521115 |
| 45 | PLK1 | 1.26973455 |
| 46 | IKBKE | 1.26355806 |
| 47 | SIK3 | 1.24535961 |
| 48 | ABL2 | 1.24061352 |
| 49 | VRK1 | 1.22561241 |
| 50 | MOS | 1.20669209 |
| 51 | CDK7 | 1.18395297 |
| 52 | ERN1 | 1.14871848 |
| 53 | MAP3K14 | 1.14036250 |
| 54 | CDK4 | 1.12557110 |
| 55 | TSSK6 | 1.12415766 |
| 56 | ATR | 1.12003520 |
| 57 | TTK | 1.11655496 |
| 58 | AURKB | 1.09770050 |
| 59 | BRSK1 | 1.09491414 |
| 60 | SMG1 | 1.09464321 |
| 61 | TRIM28 | 1.08485573 |
| 62 | TYK2 | 1.08191713 |
| 63 | MAP3K8 | 1.05262076 |
| 64 | CSF1R | 1.03532362 |
| 65 | CDK19 | 1.02464558 |
| 66 | PIM1 | 1.02142525 |
| 67 | BCR | 1.00933445 |
| 68 | SIK2 | 1.00489392 |
| 69 | CSNK1G3 | 0.98381115 |
| 70 | NEK1 | 0.95729341 |
| 71 | EPHA2 | 0.94618125 |
| 72 | CCNB1 | 0.94398335 |
| 73 | AURKA | 0.91986891 |
| 74 | ZAP70 | 0.91467912 |
| 75 | TAOK2 | 0.90056965 |
| 76 | MAP2K3 | 0.89778038 |
| 77 | IRAK2 | 0.89513194 |
| 78 | GRK6 | 0.88365279 |
| 79 | FGR | 0.87169262 |
| 80 | CHEK2 | 0.85714605 |
| 81 | MAP3K12 | 0.82227269 |
| 82 | MKNK1 | 0.80326192 |
| 83 | MATK | 0.78281407 |
| 84 | KSR2 | 0.77007949 |
| 85 | TBK1 | 0.74042097 |
| 86 | CSNK1A1L | 0.73821342 |
| 87 | BLK | 0.73705336 |
| 88 | STK10 | 0.72149503 |
| 89 | MAPK15 | 0.72005915 |
| 90 | EIF2AK3 | 0.71793147 |
| 91 | SYK | 0.71541533 |
| 92 | BRAF | 0.71211230 |
| 93 | TEC | 0.71176373 |
| 94 | NME1 | 0.70003086 |
| 95 | TAOK1 | 0.69424611 |
| 96 | DAPK3 | 0.67998953 |
| 97 | MKNK2 | 0.67591469 |
| 98 | DYRK1B | 0.65033011 |
| 99 | MAP3K1 | 0.64372936 |
| 100 | DDR2 | 0.64339740 |
| 101 | KSR1 | 0.64141206 |
| 102 | ILK | 0.63698166 |
| 103 | CSNK1G2 | 0.62850833 |
| 104 | CHEK1 | 0.61906646 |
| 105 | PLK4 | 0.61622274 |
| 106 | CSNK1G1 | 0.60832792 |
| 107 | MAPK11 | 0.59283214 |
| 108 | RAF1 | 0.58871344 |
| 109 | DAPK1 | 0.57394725 |
| 110 | EPHB2 | 0.57019600 |
| 111 | PAK1 | 0.56885429 |
| 112 | PBK | 0.51345582 |
| 113 | CDK14 | 0.50665010 |
| 114 | PDK2 | 0.50009741 |
| 115 | RPS6KA5 | 0.49765001 |
| 116 | CSNK2A2 | 0.49667415 |
| 117 | TIE1 | 0.47279250 |
| 118 | CHUK | 0.46506649 |
| 119 | PRKCI | 0.45517924 |
| 120 | CDK11A | 0.45345011 |
| 121 | LYN | 0.45162795 |
| 122 | CDK2 | 0.44294835 |
| 123 | RIPK1 | 0.43802417 |
| 124 | CSNK2A1 | 0.42593408 |
| 125 | TGFBR2 | 0.42545679 |
| 126 | CSK | 0.41647402 |
| 127 | LCK | 0.41052553 |
| 128 | CLK1 | 0.40954547 |
| 129 | IRAK4 | 0.39108834 |
| 130 | CDK18 | 0.38843409 |
| 131 | MAP2K2 | 0.36806937 |
| 132 | MAP3K3 | 0.36099839 |
| 133 | CDK15 | 0.36039279 |
| 134 | AKT2 | 0.34123540 |
| 135 | ICK | 0.33516315 |
| 136 | MST4 | 0.32954872 |
| 137 | IKBKB | 0.32423171 |
| 138 | ALK | 0.32098829 |
| 139 | CDK6 | 0.31238592 |
| 140 | MAP3K4 | 0.28418001 |
| 141 | FGFR4 | 0.27865325 |
| 142 | BMX | 0.26851614 |
| 143 | RPS6KA1 | 0.25708312 |
| 144 | MAPK4 | 0.25142175 |
| 145 | DYRK2 | 0.23185052 |
| 146 | MAP3K5 | 0.22503176 |
| 147 | FES | 0.21926216 |
| 148 | MUSK | 0.21761260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.24564098 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 5.05758764 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.04152458 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.32268976 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.23865902 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.10887111 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.86132836 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.74154627 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.67776919 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.62480498 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44139439 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.32783911 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.31802073 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.18278248 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88946497 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.87038394 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.85572047 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.83571235 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79234797 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78336160 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72134363 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56961207 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51329979 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.49064702 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48104338 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46678995 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45896270 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.44627003 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35774605 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34381492 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32086954 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.31056579 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.30274986 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27589691 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23952047 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23058468 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.23020982 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22703512 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19724729 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19362599 |
| 41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17756060 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.17172410 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15792914 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15282505 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14796377 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.13761055 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.10192288 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09690766 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09298388 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08888780 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.06966014 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.06723621 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02794197 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02631866 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00907252 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95366755 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92520326 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91726308 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90569644 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90501902 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90389590 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89528207 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87733620 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87637090 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.86186963 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86113286 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84414704 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83044670 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82256048 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79134376 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78124206 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77281148 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75613829 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74699925 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.74026152 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70007353 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64974346 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64604475 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64330687 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63860795 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.61120411 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61117575 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60443716 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60328896 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59285858 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58375886 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57644174 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56290203 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.56176124 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53769971 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53366170 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.53283479 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.52758549 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.52087008 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51136680 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50841858 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49490297 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48931696 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48635670 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47886187 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.47693622 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46787535 |
| 103 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46154450 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.45623137 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44765857 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43689364 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42977205 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42908816 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42630181 |
| 110 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42319583 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41361014 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39384596 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39023615 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.38691560 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.37840360 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36826478 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35218259 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34572169 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34518875 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34289182 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33426852 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33130712 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32834266 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30028078 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29307645 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28809364 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25719560 |
| 128 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24392543 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23845176 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.23548414 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21462637 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19660817 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19274804 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18250082 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16741924 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.15351252 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.15235923 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.14904109 |
| 139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14191845 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14151537 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13563002 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12190727 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12002607 |

